// App-Quantinova.ai

4838 : Peptide prodrugs targeting the SH2 domains of p85 block PI3K signaling

Researchers

Presenter

  • Pijus K. Mandal

Principal Investigators

  • Yanhua Yao

  • Anne R. Bresnick

  • Jonathan M. Backer

  • John S. McMurray

Medical Centers

  • 1.MD Anderson Cancer Center, Houston, TX

  • Albert Einstein College of Medicine, Great Neck, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform

  • Pyruvate dehydrogenase kinase 1

Drug/Treatment

  • Phosphatidylinositol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved